Former U.S. Surgeon General Joins WISH Indianapolis

Dr. Jerome Adams

Circle City Broadcasting’s CW affiliate WISH Indianapolis is adding former U.S. Surgeon General Dr. Jerome Adams to its medical reporting team as WISH-TV’s Medical Expert.

Circle City Owner-President-CEO DuJuan McCoy said: “As the only station with this level of dedicated medical reporting in the state of Indiana, our goal is to provide the most accurate medical news and information to our viewers. We are always focused on providing the highest-quality content in our newscasts, original programming and online at WISHTV.com, and the addition of Dr. Jerome Adams will further enhance our local and statewide medical news content.”

Adams is a former vice admiral in the U.S. Public Health Service Commissioned Corps who served as the 20th surgeon general of the United States from January 2017 to January 2021. Prior to becoming surgeon general, he served as the Indiana State Health Commissioner from 2014 to 2017.

“I am eager to get started with the team at WISH-TV,” said Dr. Adams. “I look forward to providing non-partisan news, information and knowledge regarding health and medicine to viewers, their families and all communities in the state of Indiana.”

Adams attended Indiana University School of Medicine as an Eli Lilly and Co. Scholar. He completed his internship at St. Vincent in Indianapolis in internal medicine and residency in anesthesiology at Indiana University. Adams also received a Master of Public Health degree from the University of California, Berkeley with a focus on chronic disease prevention. After his tenure as surgeon general, he returned to Indiana and currently practices medicine in the Indianapolis area.

BRAND CONNECTIONS

“WISH-TV remains focused on providing important information to improve the overall health literacy in our communities,” said Al Carl, WISH news director. “Providing thorough medical news and information is one of the ways we can help our viewers maintain or improve their health and well-being.”


Comments (0)

Leave a Reply